Gypsopiea Pharmaceutical Private Limited
Pharmaceutical company specializing in trading medical products.
2018 | Pune, Maharashtra (India) | Active
Gypsopiea Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 93.06%
- Profit Growth 267.62%
- Ebitda 264.24%
- Net Worth 199.80%
- Total Assets 60.35%
About Gypsopiea Pharmaceutical
Gypsopiea Pharmaceutical Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 October 2018 (Six years and four months 12 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Imran Shaikh, Alok Pradhan, Avinash Kadam, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52609PN2018PTC179741
- Company No.
179741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Pharma
Who are the key members and board of directors at Gypsopiea Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Imran Shaikh  | Director | 23-Oct-2018 | Current |
| Alok Pradhan | Director | 23-Oct-2018 | Current |
| Avinash Kadam | Additional Director | 26-Mar-2019 | Current |
| Sagar Bhapkar | Additional Director | 26-Mar-2019 | Current |
Financial Performance of Gypsopiea Pharmaceutical.
Gypsopiea Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.06% increase. The company also saw a substantial improvement in profitability, with a 267.62% increase in profit. The company's net worth Soared by an impressive increase of 199.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gypsopiea Pharmaceutical?
In 2021, Gypsopiea Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gypsopiea Pharmaceutical?
Gypsopiea Pharmaceutical has a workforce of 19 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gypsopiea Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gypsopiea Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Gypsopiea Pharmaceutical
Recent activity within the organization
- Annual General Meeting
Gypsopiea Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Gypsopiea Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
- Director Appointment
Avinash Bhausaheb Kadam was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2019 & has been associated with this company since 5 years 11 months .
- Director Appointment
Sagar Gajanan Bhapkar was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2019 & has been associated with this company since 5 years 11 months .
- Director Appointment
Imran Adam Shaikh was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 6 years 4 months .
- Director Appointment
Alok Kumar Pradhan was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 6 years 4 months .
Frequently asked questions
What is the Incorporation or founding date of Gypsopiea Pharmaceutical Private Limited?
Gypsopiea Pharmaceutical Private Limited was incorporated on 23 Oct 2018.
What is authorized share capital and paid-up capital of Gypsopiea Pharmaceutical Private Limited?
The authorized share capital of Gypsopiea Pharmaceutical Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Gypsopiea Pharmaceutical Private Limited?
Currently 4 directors are associated with Gypsopiea Pharmaceutical Private Limited.
- Imran Adam Shaikh
- Alok Kumar Pradhan
- Avinash Bhausaheb Kadam
- Sagar Gajanan Bhapkar
What is the registered address of Gypsopiea Pharmaceutical Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Gypsopiea Pharmaceutical Private Limited is Sr No 4/2/1/1 Lane 04 Kakade Wasti India, Pune, Maharashtra, 411048.
What is the corporate identification number (CIN) and company number of Gypsopiea Pharmaceutical Private Limited?
The corporate identification number (CIN) of Gypsopiea Pharmaceutical Private Limited is U52609PN2018PTC179741 and the company number is 179741 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Gypsopiea Pharmaceutical Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Gypsopiea Pharmaceutical Private Limited has risen by 93.06%.
How many employees does Gypsopiea Pharmaceutical Private Limited currently have?
As Per 2022 financial reports, 19 employees are currently employed by Gypsopiea Pharmaceutical Private Limited.
What change has been observed in the net worth of Gypsopiea Pharmaceutical Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Gypsopiea Pharmaceutical Private Limited has experienced an upsurge of 199.80%.
When was the last Balance Sheet of Gypsopiea Pharmaceutical Private Limited filed with the ROC?
The most recent Balance Sheet for Gypsopiea Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2024.